According to the ESTIMATE scores, there was a negative correlation between FDX1 expression and stromal and immune cell content in the TME of ACC, KIRC, STAD, and THCA, but not in LGG and SARC. This evidence concerns the gene FDX1 and adrenal cortex carcinoma.